Previous Article | Next Article ![]()
Infection and Immunity, June 2000, p. 3103-3107, Vol. 68, No. 6
Biology Department, Bates College, Lewiston,
Maine 042401; School of Dental Hygiene,
University of New England, Portland, Maine
041032; and The Jackson Laboratory, Bar
Harbor, Maine 046093
Received 30 September 1999/Returned for modification 29 December
1999/Accepted 1 March 2000
Alveolar bone resorption can be induced in specific-pathogen-free
mice by oral infection with Porphyromonas gingivalis
(P. J. Baker, R. T. Evans, and D. C. Roopenian, Arch.
Oral Biol. 39:1035-1040, 1994). Here we used a mouse strain, C57BL/6J,
which is relatively resistant to P. gingivalis-induced bone
loss to examine whether partial or complete deletion of various
adhesion molecules would increase susceptibility. Complete deletion of
P-selectin or nearly complete lack of expression of intercellular
adhesion molecule 1 (ICAM-1) led to increased susceptibility to bone
resorption after oral infection, while a hypomorphic defect in
Periodontal diseases are chronic
inflammatory diseases which destroy the supporting tissues around the
teeth and can lead to tooth loss. One aspect of periodontal disease is
resorption of the alveolar bone, which forms the bony sockets to which
the teeth are anchored (19, 23, 27). In the initiation of
periodontal disease, cells of the innate immune system are recruited to
the gingiva; neutrophils are thought to be protective against the disease (10). Periodontal disease in humans is associated
with the black-pigmented, gram-negative anaerobic bacterium
Porphyromonas gingivalis (18, 22, 25). Humans
develop a variety of adaptive immune responses to P. gingivalis during the course of the disease (8, 9).
Using a mouse model in which oral infection with P. gingivalis results in loss of alveolar bone, we have previously
shown that one aspect of the adaptive immune response, CD4+
T cells and their cytokines, rather than being protective, contribute to destructive bone remodeling (4). Here, using the same
model, we examine the effects of adhesion molecule deficiencies on bone loss. Such deficiencies lead to defects in both innate and adaptive immunity, due in part to the role of adhesion molecules in
extravasation of leukocytes from the circulation into the tissues.
Several families of adhesion molecules are utilized at different
steps of the extravasation process. Neutrophil and macrophage rolling,
the initial step in their leaving the blood vessel, is mediated by
selectins upregulated by endothelial cells, such as those in blood
vessels, in response to activation signals such as C5a,
interleukin-1 In addition to their roles in innate immunity, two of these adhesion
molecules are also important in adaptive immunity. Integrin binding to
ICAM-1 is a costimulatory signal for T- and B-lymphocyte activation, in
addition to their extravasation (12).
In this study, we investigated the consequences of adhesion defects by
comparing three strains of mice with a range of severity of adhesion
deficiencies. One strain has a hypomorphic allele at the CD18 locus,
resulting in decreased CD18 expression and thus in reduced cell surface
expression of all of the Animals.
Specific-pathogen-free mice were bred and raised at
The Jackson Laboratory (Bar Harbor, Maine). ICAM-1-deficient
C57BL/6J-Icam1tm1Bay (21),
CD18-deficient C57BL/6J-Itgb2tm1Bay mice
(28), and P-selectin (Selp)-deficient
C57BL/6J-Selptm1Bay mice were produced by
gene targeting of strain 129-derived embryonal stem cells
followed by at least 10 generations of backcrossing onto the
C57BL/6J background mice. These mice and their wild-type C57BL/6J
controls were kept on a 12-h light-dark cycle and received distilled
water and food ad libitum. The animals within an experiment were
age-matched females, 10 to 15 weeks old at the start of experiments. All experiments were approved by the Animal Care and Use Committee, Bates College.
Bacteria.
P. gingivalis ATCC 53977 (A7A1-28) was
maintained frozen in defibrinated sheep blood at Oral infection.
As described previously (4), mice
were given sulfamethoxazole-trimethoprim (Sulfatrim; Goldline
Laboratories, Fort Lauderdale, Fla.), 10 ml per pint in deionized
water, ad libitum for 10 days. This was followed by a 3-day
antibiotic-free period. The mice were then infected with
109 CFU of live P. gingivalis in 100 µl of
phosphate-buffered saline with 2% carboxymethylcellulose
(15) placed into the esophagus and oral cavity three times
at 2-day intervals. Controls included sham-infected mice which received
the antibiotic pretreatment and the carboxymethylcellulose gavage but
without P. gingivalis. At 47 days after the first gavage,
the mice were euthanized by CO2 inhalation.
Recovery of P. gingivalis.
A sterile medium-sized
paper point (Johnson & Johnson, East Windsor, N.J.) was held against
the gumline of the upper molars for 5 s and then vortexed in 1 ml
of prereduced brain heart infusion broth supplemented with hemin and
menadione. An aliquot plated onto supplemented blood agar was incubated
anaerobically for 4 weeks. P. gingivalis colonies were
identified by their black pigmentation and by Gram stain
(2).
P. gingivalis-specific IgG.
Blood was collected
from each mouse at the time of euthanasia. Sera were stored at Alveolar bone loss.
Horizontal bone loss around the
maxillary molars was assessed by a morphometric method (15).
Skulls were defleshed after 10 min of treatment in boiling water under
15-lb/in2 pressure, immersed overnight in 3% hydrogen
peroxide, pulsed for 1 min in bleach, and stained with 1% methylene
blue. The distance from the cementoenamel junction (CEJ) to the
alveolar bone crest (ABC) was measured at a total of 14 buccal sites
per mouse. This measurement is referred to below as CEJ to ABC.
Measurements were made under a dissecting microscope (magnification,
×40) fitted with a video image marker measurement system (model VIA
170; Boeckeler Instruments, Inc., Tucson, Ariz.) standardized to give
measurements in millimeters. Bone measurements were made a total of
three times in a random and blinded protocol by two evaluators. In some
cases the CEJ-to-ABC measurements are shown directly. In other cases, data are shown as the number of millimeters of bone lost in infected animals: the "total millimeter change in bone" was calculated by
subtracting the CEJ to ABC of individual mice from the mean CEJ to ABC
of groups of sham-infected mice, totaled for the 14 measurement sites.
Since the CEJ-to-ABC increases if bone is resorbed, this calculation
gives negative values of "total millimeter change in bone" when
there has been bone loss.
Statistics.
Differences between groups were evaluated by the
t test (Excel; Microsoft).
The effects of deletion of different adhesion molecules on
alveolar bone loss after oral infection with P. gingivalis
are shown in Fig. 1. A hypomorphic allele
of CD18, leading to reduced expression of all
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Adhesion Molecule Deficiencies Increase Porphyromonas
gingivalis-Induced Alveolar Bone Loss in Mice
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
2-integrins did not. Both the total amount of bone lost
and the number of sites at which there was significant loss were
increased in mice deficient in either ICAM-1 or P-selectin. Each of the
three adhesion molecule deficiencies was sufficient to decrease
P. gingivalis-specific serum immunoglobulin G responses,
but lower antibody titers did not lead to increased bone loss in
partially
2-integrin-deficient mice. In conclusion,
P-selectin and ICAM-1 deficiencies increase susceptibility to and
severity of alveolar bone loss after P. gingivalis
infection. This finding underscores the importance of innate immunity
in protection against P. gingivalis-induced alveolar bone resorption.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
, and tumor necrosis factor alpha. The integrin family
of adhesion molecules on leukocytes then bind to the intercellular adhesion molecules (ICAM-1 and ICAM-2) on endothelial cells, attaching the leukocytes to the endothelial walls and aiding in transendothelial migration (28). The
2-integrins consist of a
common
2 subunit (CD18) coexpressed with one of several
subunits (CD11a in lymphocyte function antigen LFA-1, CD11b in
complement receptor type 3 [CR3 or Mac-1], and CD11c in complement
receptor type 4 [CR4 or p150,95]) (1, 28). All three are
present on neutrophils and macrophages. In addition to their role in
granulocyte extravasation, the
2-integrins function in
neutrophil phagocytosis and respiratory burst (1). ICAM-1
and ICAM-2 are expressed on leukocytes, epithelium, and fibroblasts in
addition to endothelium and are upregulated by stimulation with
bacterial lipopolysaccharide or inflammatory cytokines (14).
2-integrins. These mice are a
model for the moderate form of human CD18 deficiency (28).
The second mouse strain is severely but not entirely deficient in
ICAM-1; these mice do express low levels of cell surface ICAM-1, but
the expression is more severely inhibited than is integrin expression
in the CD18 mutant mice (21, 28). However, even when mice
are completely deficient in cell surface ICAM-1, neutrophil transendothelial migration is not completely eliminated, indicating that there are ICAM-1-independent mechanisms for extravasation (21). Therefore, we also tested a third mouse strain, in
which there is a complete lack of expression of P-selectin. Both
ICAM-dependent and ICAM-independent mechanisms of leukocyte emigration
are blocked in P-selectin-deficient mice (17). The three
mutant mouse strains thus provide a graded series of adhesion defects.
We examined the effects of different degrees of adhesion molecule
deficiency on alveolar bone loss in response to P. gingivalis and on specific antibody responses after infection.
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
70°C and by weekly
transfer on supplemented blood agar (Trypticase soy agar base with
0.1% yeast extract, 5.0 µg of hemin per ml, 0.5 µg of menadione
per ml, and 5% defibrinated sheep blood). For experiments, the
bacteria were anaerobically grown under 5% CO2-10%
H2-85% N2 on supplemented blood agar at 37°C for 4 to 7 days.
70°C
for later assessment of specific immunoglobulin G (IgG) antibody by
enzyme-linked immunosorbent assay, as described previously
(2), in polystyrene plates (Falcon, Becton-Dickinson
Labware, Lincoln Park, N.J.) coated with formalin-killed whole P. gingivalis ATCC 53977. The enzyme-linked immunosorbent assay titer
was defined as the reciprocal of the highest serum dilution (expressed
in log2) which produced absorbance readings more than two
standard deviations above background levels. Values in sham-infected
mice were only slightly greater than zero and have been subtracted from
the titers in infected mice shown in Fig. 4.
![]()
RESULTS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
2-integrins, did not render mice more susceptible to
bone loss after infection (P > 0.05), (Fig. 1A). A
more severely hypomorphic allele of ICAM-1 (Fig. 1B) or a complete
deletion of P-selectin (Fig. 1C) did, however, render C57BL/6J mice
more susceptible to bone loss (P < 0.05).
Bone loss was not evenly distributed at all sites, and deletion of
ICAM-1 or P-selectin increased its distribution. Although bone loss in
infected wild-type C57BL/6J mice was not significant when all 14 sites
were considered (Fig. 1), there were individual sites with significant
bone loss (P < 0.05), as shown in Fig. 2A and Fig.
3A. Infection of ICAM-1-deficient mice
(Fig. 2B) or P-selectin knockout mice (Fig. 3B), but not of partially
2-integrin-deficient mice (data not shown), induced bone
loss at a greater number of sites.

View larger version (17K):
[in a new window]
FIG. 1.
Deficiency of ICAM-1 or P-selectin, but not
2-integrin, increases susceptibility to alveolar bone
loss after oral infection with P. gingivalis. Data are the
means and 1 standard error of the mean (n = 8) of the
number of millimeters of change in the CEJ-ABC at the total of 14 sites
in infected mice compared to sham-infected mice. Panels A, B, and C
show results of separate experiments. (A) Neither wild-type C57BL/6J
control mice nor
2-integrin-deficient C57BL/6J mice lost
bone after infection. Data shown for infected mice are not
significantly different from those for sham-infected mice (P > 0.05). (B) Wild-type C57BL/6J mice did not lose bone after
infection, but ICAM-1-deficient C57BL/6J mice did. (C) Wild-type
C57BL/6J mice did not lose bone after infection, but
P-selectin-deficient C57BL/6J mice did. *, infected mice were
different from sham-infected mice (P < 0.05);
,
infected mice lost significantly more bone than infected wild-type
C57BL/6J mice did (P < 0.05).

View larger version (21K):
[in a new window]
FIG. 2.
ICAM-1-deficient mice show more sites with bone loss
after P. gingivalis oral infection than do wild-type
C57BL/6J mice. Data are the means and 1 standard error of the mean for
eight mice. *, infected mice different from sham-infected mice
(P < 0.05).

View larger version (22K):
[in a new window]
FIG. 3.
P-selectin (Selp)-deficient mice have more sites with
bone loss after P. gingivalis oral infection than do
wild-type C57BL/6J mice. Data are the means ± 1 standard error of
the mean for eight mice. *, infected mice different from
sham-infected mice (P < 0.05).
2-integrin-deficient mice
(data not shown).
Deficiency of any of the three adhesion molecules decreased antibody
responses to oral infection (Fig. 4).
P. gingivalis-specific IgG titers were zero in sham-infected
mice and were significantly (P < 0.05) elevated in
infected immunocompetent C57BL/6J mice. Specific IgG titers were also
zero in sham-infected
2-integrin-, ICAM-1- or
P-selectin-deficient mice; however, in these mice, the titer did not
increase after infection. The titers in infected adhesion
molecule-deficient mice were not significantly different (P > 0.05) from those in sham-infected adhesion molecule-deficient mice.
|
|
| |
DISCUSSION |
|---|
|
|
|---|
C57BL/6J mice are fairly resistant to alveolar bone loss after
infection with P. gingivalis compared with other
immunocompetent mouse strains such as BALB/c (P. J. Baker, M. Dixon, and D. C. Roopenian, submitted for publication). Among the
three adhesion molecules examined, a hypomorphic
2-integrin allele was not a defect sufficient to
overcome the resistance of the C57BL/6J parent strain whereas both a
more severely hypomorphic allele of ICAM-1 and a complete abrogation of
P-selectin made C57BL/6J mice more susceptible to bone loss. Whether
differential susceptibility in the adhesion mutants is due to
differences in the degree of expression or to something more specific
to the different types of adhesion molecules remains to be established.
We cannot say definitively whether our results are due to changes in
cell-mediated immunity or changes in innate immunity, although several
lines of evidence indicate that impaired innate immunity is the more
plausible explanation.
2-Integrins and ICAMs, but not
P-selectin, are involved in lymphocyte activation (12). If
adaptive immunity is primarily protective, strains with impaired lymphocyte activation should show increased bone loss; conversely, if
specific immunity does not protect against bone loss, its abrogation would not increase bone loss. We have previously shown that the adaptive antibody response, particularly the low levels that are induced by oral infection in this model, is not protective; although antibody develops in immune normal mice before the onset of detectable bone loss, it does not prevent it (3). Here we show that
although antibody responses were decreased in all three mouse strains
(Fig. 4), only two of the three strains showed increased susceptibility to bone loss after oral infection (Fig. 1). In terms of cell-mediated adaptive immunity, we have previously reported that CD4+ T
cells contribute to alveolar bone loss induced by oral infection with
P. gingivalis (4), a finding that is consistent
with the T-cell response being destructive rather than protective. If
cell-mediated immunity is destructive, mice with diminished
cell-mediated immunity (12, 21) should show less bone loss,
not the increased bone loss we found in infected adhesion
molecule-deficient mice.
An alternative explanation for our results is that susceptibility is
caused by weakened innate antibacterial immune mechanisms. Our results
do not correlate with the known effects of adhesion molecules on
lymphocytes but are in line with the degree of inhibition of
neutrophils in the three immunodeficient mouse strains.
P-selectin-deficient mice exhibited increased bone loss after
infection, but P-selectin is not known to be directly involved in
lymphocyte activation, and mice deficient in
2-integrin,
which does function in lymphocyte activation, did not show increased
bone loss. Adhesion molecule deficiencies decrease the numbers of
neutrophils at an infection site, and the three mouse strains we used
vary in the degree of their neutrophil defects (17, 21, 28).
The
2-integrin-deficient mouse strain we used has the
smallest defect in neutrophil emigration and did not show altered bone
loss compared to immune normal mice, while the P-selectin-deficient
strain has the greatest extravasation defect and exhibited increased
susceptibility to bone loss.
If neutrophils are primarily proinflammatory, a defect in adhesion molecules might be expected to decrease bone loss. On the other hand, neutrophils are thought to be protective against periodontal disease and can kill P. gingivalis (10), so that a decrease might make bone loss worse. Although disease severity increased in ICAM-1-deficient and P-selectin-deficient mice, we did not see higher percentages of P. gingivalis in infected adhesion molecule-deficient mice than in infected immunocompetent mice (Fig. 5). However, because we did not perform limiting-dilution analyses of the total oral flora, we cannot rule out the possibility that the total bacterial load was greater in the adhesion-deficient mice.
The integrins were the least inhibited of the molecules and may have
been sufficient to afford protection, since we did not see increased
bone loss in our partially
2-integrin-deficient mice.
Patients with Mac-1 integrin deficiencies often develop periodontal
disease, but the disease severity depends on the degree of the defect
(26). Other contributions of the genetic background may have
overcome the integrin defect. Indeed, studies have indicated that other
inflammatory diseases do not result from integrin defects unless they
are combined with other defects (6). P. gingivalis can use the integrins (CD11/ CD18) as attachment sites
for binding to macrophages, inducing interleukin-1
and tumor
necrosis factor alpha gene expression in these host cells
(24). Since these cytokines induce bone resorption (5,
11, 16), integrins may tip the balance toward destructive
inflammation rather than protection. If so, an integrin defect would
not promote bone loss, which is in line with the lack of bone loss in
our integrin-deficient mice.
In contrast to the proinflammatory activities of the integrins, soluble P-selectin is anti-inflammatory in vitro and P-selectin deficiency leads to a worsening of some experimental inflammatory diseases (20). ICAM can also be anti-inflammatory. Human rheumatoid arthritis patients have been helped by anti-ICAM antibodies (13), and the improvement was associated with decreased T-cell activity (7), which is in line with our previous finding that CD4+-T-cell deficiencies decrease alveolar bone loss (4).
These results, in addition to our findings, are most consistent with a protective role for some adhesion molecules through their regulation of innate immune mechanisms. The amplification of such innate protective immune responses without inducing destructive adaptive immunity may be a useful way to prevent periodontal disease.
| |
ACKNOWLEDGMENTS |
|---|
We thank Teresa Hopkins and Tom Sproule for their contributions to this project.
This work was supported by Public Health Service grants R29 DE10728 (to P.J.B.) and R01 AI24544 (to D.C.R.) from the National Institutes of Health and by a grant to Bates College from the Howard Hughes Medical Institute.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Biology Department, Bates College, Lewiston, ME 04240. Phone: (207) 786-6108. Fax: (207) 786-8334. E-mail: pbaker{at}bates.edu.
Editor: J. D. Clements
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Anderson, D. C., L. J. Miller, F. C. Schmalstieg, R. Rothlein, and T. A. Springer. 1986. Contributions of the Mac-1 glycoprotein family to adherence dependent granulocyte functions: structure-function assessments employing subunit-specific monoclonal antibodies. J. Immunol. 137:15-27[Abstract]. |
| 2. | Baker, P. J., R. T. Evans, and D. C. Roopenian. 1994. Oral infection with Porphyromonas gingivalis and induced alveolar bone loss in immunocompetent and severe combined immunodeficient mice. Arch. Oral Biol. 39:1035-1040[CrossRef][Medline]. |
| 3. | Baker, P. J., S. Carter, M. Dixon, R. T. Evans, and D. C. Roopenian. 1999. Serum antibody response to oral infection precedes but does not prevent Porphyromonas gingivalis-induced alveolar bone loss in mice. Oral Microbiol. Immunol. 14:194-196[CrossRef][Medline]. |
| 4. |
Baker, P. J.,
R. T. Evans, and D. C. Roopenian.
1999.
CD4+ T cells and the proinflammatory cytokines interferon gamma and interleukin-6 contribute to alveolar bone loss in mice.
Infect. Immun.
67:2804-2809 |
| 5. | Bertolini, D. R., T. Nedwin, T. Bringman, D. Smith, and G. R. Mundy. 1985. Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors. Nature. 319:516-518. |
| 6. |
Bullard, D. C.,
K. Scharffetter-Kochanek,
M. J. McArthur,
J. G. Chosay,
M. McBride,
C. A. Montgomery, and A. L. Beaudet.
1996.
A polygenic mouse model of psoriasiform skin disease in CD18-deficient mice.
Proc. Natl. Acad. Sci. USA
93:2116-2121 |
| 7. | Davis, L. S., A. F. Kavanaugh, L. A. Nichols, and P. E. Lipsky. 1995. Induction of persistent T-cell hyporesponsiveness in vivo by monoclonal antibody to ICAM in patients with rheumatoid arthritis. J. Immunol. 154:3235-3537. |
| 8. | Ebersole, J. L., M. A. Taubman, D. J. Smith, D. E. Frey, A. D. Haffajee, and S. S. Socransky. 1987. Human serum antibody responses to oral microorganisms. IV. Correlation with homologous infection. Oral Microbiol. Immunol. 12:53-59. |
| 9. | Genco, R. J. 1992. Host responses in periodontal diseases: current concepts. J. Periodontol. 63:338-355[Medline]. |
| 10. |
Genco, R. J.,
T. E. van Dyke,
M. J. Levine,
R. D. Nelson, and M. E. Wilson.
1986.
Molecular factors influencing neutrophil defects in periodontal disease.
J. Dent. Res.
65:1379-1391 |
| 11. |
Hanazawa, S.,
Y. Murakami,
K. Hirose,
S. Anamo,
Y. Ohmori,
H. Higuchi, and S. Kitano.
1991.
Bacteroides (Porphyromonas) gingivalis fimbriae activate mouse peritoneal macrophages and induce gene expression and production of interleukin-1.
Infect. Immun.
59:1972-1979 |
| 12. | Janeway, C. A., P. Travers, M. Walport, and J. D. Capra. 1999. Immunobiology: the immune system in health and disease. Garland Publishing, New York, N.Y. |
| 13. | Kavanaugh, A. F., L. S. Davis, L. A. Nichols, S. H. Norris, R. Rothlein, L. A. Scharschmidt, and P. E. Lipsky. 1994. Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule-1. Arthritis Rheum. 37:992-999[Medline]. |
| 14. | King, P. D., E. T. Sandberg, A. Selvakumar, P. Fang, A. L. Beaudet, and B. Dupont. 1995. Novel isoforms of murine intercellular adhesion molecule-1 generated by alternative RNA splicing. J. Immunol. 154:6080-6093[Abstract]. |
| 15. | Klausen, B., R. T. Evans, and C. Sfintescu. 1989. Two complementary methods of assessing periodontal bone level in rats. Scand. J. Dent. Res. 97:494-499[Medline]. |
| 16. | Kornman, K. S., A. Crane, H.-Y. Wang, F. S. di Giovine, M. G. Newman, F. W. Pirk, T. G. Wilson, F. L. Higginbottom, and G. W. Duffy. 1997. The interleukin-1 genotype as a severity factor in adult periodontal disease. J. Clin. Periodontol. 24:72-77[CrossRef][Medline]. |
| 17. | Mizgerd, J. P., W. M. Quinlan, B. W. LeBlanc, G. J. Kutkoski, D. C. Bullard, A. L. Beaudet, and C. M. Doerschuk. 1998. Combinatorial requirements for adhesion molecules in mediating neutrophil emigration during bacterial peritonitis in mice. J. Leukoc. Biol. 64:291-297[Abstract]. |
| 18. |
Okuda, K., and I. Takazoe.
1988.
The role of Bacteroides gingivalis in periodontal disease.
Adv. Dent. Res.
2:260-268 |
| 19. | Page, R. C., and H. E. Schroeder. 1982. Periodontitis in man and other animals: a comparative review. S. Karger, Basel, Switzerland. |
| 20. | Rosenkranz, A. R., D. L. Mendrick, R. S. Cotran, and T. N. Mayadas. 1999. P-selectin deficiency exacerbates experimental glomerulonephritis: a protective role for endothelial P-selectin in inflammation. J. Clin. Investig. 103:649-659[Medline]. |
| 21. |
Sligh, J. E.,
C. M. Ballantyne,
S. S. Rich,
H. K. Hawkins,
C. W. Smith,
A. Bradley, and A. L. Beaudet.
1993.
Inflammatory and immune responses are impaired in mice deficient in intercellular adhesion molecule 1.
Proc. Natl. Acad. Sci. USA
90:8529-8533 |
| 22. | Slots, J., and M. A. Listgarten. 1988. Bacteroides gingivalis, Bacteroides intermedius and Actinobacillus actinomycetemcomitans in human periodontal diseases. J. Clin. Periodontol. 15:85-93[CrossRef][Medline]. |
| 23. | Suzuki, J. B. 1988. Diagnosis and classification of the periodontal diseases. Den. Clin. North Am. 32:195-216. |
| 24. |
Takeshita, A.,
Y. Murakami,
Y. Yamashita,
M. Ishida,
S. Fujisawa,
S. Kitano, and S. Hanazawa.
1998.
Porphyromonas gingivalis fimbriae use 2 integrin (CD11/CD18) on mouse peritoneal macrophages as a cellular receptor, and the CD18 chain plays a functional role in fimbrial signalling.
Infect. Immun.
66:4056-4060 |
| 25. | van Winkelhoff, A. J., T. J. M. van Steenbergen, and J. de Graaff. 1993. Occurrence and association with disease, p. 33-42. In H. N. Shah, D. Mayrand, and R. J. Genco (ed.), Biology of the species Porphyromonas gingivalis. CRC Press, Inc., Boca Raton, Fla. |
| 26. | Waldrop, T. C., D. C. Anderson, W. W. Hallmon, F. C. Schmalsteig, and R. L. Jacobs. 1987. Periodontal manifestations of the heritable Mac-1, LFA-1, deficiency syndrome. Clinical, histopathological and molecular characteristics. J. Periodontol. 58:400-416[Medline]. |
| 27. | Williams, R. C. 1990. Periodontal disease. N. Engl. J. Med. 322:373-382[Medline]. |
| 28. | Wilson, R. W., C. M. Ballantyne, C. W. Smith, C. Montgomery, A. Bradley, W. E. O'Brien, and A. L. Beaudet. 1993. Gene targeting yields a CD18-mutant mouse for study of inflammation. J. Immunol. 151:1571-1578[Abstract]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»